| Literature DB >> 17540359 |
Andrew Lindsley1, Paige Snider, Hongming Zhou, Rhonda Rogers, Jian Wang, Michael Olaopa, Agnieszka Kruzynska-Frejtag, Shrinagesh V Koushik, Brenda Lilly, John B E Burch, Anthony B Firulli, Simon J Conway.
Abstract
Periostin is a fasciclin-containing adhesive glycoprotein that facilitates the migration and differentiation of cells that have undergone epithelial-mesenchymal transformation during embryogenesis and in pathological conditions. Despite the importance of post-transformational differentiation as a general developmental mechanism, little is known how periostin's embryonic expression is regulated. To help resolve this deficiency, a 3.9-kb periostin proximal promoter was isolated and shown to drive tissue-specific expression in the neural crest-derived Schwann cell lineage and in a subpopulation of periostin-expressing cells in the cardiac outflow tract endocardial cushions. In order to identify the enhancer and associated DNA binding factor(s) responsible, in vitro promoter dissection was undertaken in a Schwannoma line. Ultimately a 304-bp(peri) enhancer was identified and shown to be capable of recapitulating 3.9 kb(peri-lacZ)in vivo spatiotemporal patterns. Further mutational and EMSA analysis helped identify a minimal 37-bp region that is bound by the YY1 transcription factor. The 37-bp enhancer was subsequently shown to be essential for in vivo 3.9 kb(peri-lacZ) promoter activity. Taken together, these studies identify an evolutionary-conserved YY1-binding 37-bp region within a 304-bp periostin core enhancer that is capable of regulating simultaneous novel tissue-specific periostin expression in the cardiac outflow-tract cushion mesenchyme and Schwann cell lineages.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17540359 PMCID: PMC1995123 DOI: 10.1016/j.ydbio.2007.04.041
Source DB: PubMed Journal: Dev Biol ISSN: 0012-1606 Impact factor: 3.582